Is Management of Central Retinal Artery Occlusion the Next Frontier in Cerebrovascular Diseases?

We thank the editors for allowing us to reply to the exhaustive commentary by Professor Sohan Singh Hayerh to our recent review.1 We note that his criticisms of our paper are quite similar to those that he submitted in response to the EAGLE trial.2 The response by Feltgen et al3 has answered the limitations of the points he raises and hence we do not wish to again reiterate the same here.
Source: Journal of Stroke and Cerebrovascular Diseases - Category: Neurology Authors: Tags: Letter to the Editor Source Type: research
More News: Stroke | Vitamin A